538 related articles for article (PubMed ID: 24433041)
1. Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery.
Luttrell LM
Mol Endocrinol; 2014 Mar; 28(3):281-94. PubMed ID: 24433041
[TBL] [Abstract][Full Text] [Related]
2. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.
Luttrell LM; Maudsley S; Bohn LM
Mol Pharmacol; 2015 Sep; 88(3):579-88. PubMed ID: 26134495
[TBL] [Abstract][Full Text] [Related]
3. Translating in vitro ligand bias into in vivo efficacy.
Luttrell LM; Maudsley S; Gesty-Palmer D
Cell Signal; 2018 Jan; 41():46-55. PubMed ID: 28495495
[TBL] [Abstract][Full Text] [Related]
4. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
[TBL] [Abstract][Full Text] [Related]
5. Refining efficacy: exploiting functional selectivity for drug discovery.
Gesty-Palmer D; Luttrell LM
Adv Pharmacol; 2011; 62():79-107. PubMed ID: 21907907
[TBL] [Abstract][Full Text] [Related]
6. Biased agonism at the parathyroid hormone receptor: a demonstration of functional selectivity in bone metabolism.
Bohinc BN; Gesty-Palmer D
Mini Rev Med Chem; 2012 Aug; 12(9):856-65. PubMed ID: 22681253
[TBL] [Abstract][Full Text] [Related]
7. Arrestin pathways as drug targets.
Luttrell LM
Prog Mol Biol Transl Sci; 2013; 118():469-97. PubMed ID: 23764065
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.
Reiter E; Ahn S; Shukla AK; Lefkowitz RJ
Annu Rev Pharmacol Toxicol; 2012; 52():179-97. PubMed ID: 21942629
[TBL] [Abstract][Full Text] [Related]
9. Biased agonism: An emerging paradigm in GPCR drug discovery.
Rankovic Z; Brust TF; Bohn LM
Bioorg Med Chem Lett; 2016 Jan; 26(2):241-250. PubMed ID: 26707396
[TBL] [Abstract][Full Text] [Related]
10. Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data.
Stott LA; Hall DA; Holliday ND
Biochem Pharmacol; 2016 Feb; 101():1-12. PubMed ID: 26478533
[TBL] [Abstract][Full Text] [Related]
11. Orthosteric- and allosteric-induced ligand-directed trafficking at GPCRs.
Digby GJ; Conn PJ; Lindsley CW
Curr Opin Drug Discov Devel; 2010 Sep; 13(5):587-94. PubMed ID: 20812150
[TBL] [Abstract][Full Text] [Related]
12. Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology.
DeWire SM; Violin JD
Circ Res; 2011 Jul; 109(2):205-16. PubMed ID: 21737816
[TBL] [Abstract][Full Text] [Related]
13. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
Xiao K; Sun J
Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
[TBL] [Abstract][Full Text] [Related]
14. Allosteric coupling and biased agonism in G protein-coupled receptors.
Bock A; Bermudez M
FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
[TBL] [Abstract][Full Text] [Related]
15. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.
Slosky LM; Caron MG; Barak LS
Trends Pharmacol Sci; 2021 Apr; 42(4):283-299. PubMed ID: 33581873
[TBL] [Abstract][Full Text] [Related]
16. A kinetic view of GPCR allostery and biased agonism.
Lane JR; May LT; Parton RG; Sexton PM; Christopoulos A
Nat Chem Biol; 2017 Aug; 13(9):929-937. PubMed ID: 28820879
[TBL] [Abstract][Full Text] [Related]
17. Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective.
Shonberg J; Lopez L; Scammells PJ; Christopoulos A; Capuano B; Lane JR
Med Res Rev; 2014 Nov; 34(6):1286-330. PubMed ID: 24796277
[TBL] [Abstract][Full Text] [Related]
18. Biased ligands at G-protein-coupled receptors: promise and progress.
Violin JD; Crombie AL; Soergel DG; Lark MW
Trends Pharmacol Sci; 2014 Jul; 35(7):308-16. PubMed ID: 24878326
[TBL] [Abstract][Full Text] [Related]
19. Emergent biological properties of arrestin pathway-selective biased agonism.
Appleton KM; Luttrell LM
J Recept Signal Transduct Res; 2013 Jun; 33(3):153-61. PubMed ID: 23448506
[TBL] [Abstract][Full Text] [Related]
20. Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors.
Lymperopoulos A
Curr Pharm Des; 2012; 18(2):192-8. PubMed ID: 22229558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
